LogicBio Therapeutics

OverviewSuggest Edit

LogicBio Therapeutics, a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect.

TypePublic
Founded2014
HQCambridge, US
Websitelogicbio.com

Latest Updates

Employees (est.) (Dec 2018)23
Job Openings2
Share Price (Oct 2019)$10.3 (+2%)

Key People/Management at LogicBio Therapeutics

Frederic Chereau

Frederic Chereau

CEO

LogicBio Therapeutics Office Locations

LogicBio Therapeutics has an office in Cambridge
Cambridge, US (HQ)
610 Main St 3rd Floor
Show all (1)

LogicBio Therapeutics Financials and Metrics

LogicBio Therapeutics Revenue

USD

Net income (FY, 2018)

(17.6m)

EBIT (FY, 2018)

(17.9m)

Market capitalization (16-Oct-2019)

233.7m

Closing stock price (16-Oct-2019)

10.3

Cash (31-Dec-2018)

80.9m
LogicBio Therapeutics's current market capitalization is $233.7 m.
Annual
USDFY, 2016FY, 2017FY, 2018

General and administrative expense

1.4m2.3m6.9m

R&D expense

2.0m3.6m11.1m

Operating expense total

3.4m5.9m17.9m

EBIT

(3.4m)(5.9m)(17.9m)
Quarterly
USDQ3, 2017Q3, 2018

General and administrative expense

470.0k2.1m

R&D expense

580.0k2.4m

Operating expense total

1.1m4.6m

EBIT

(1.0m)(4.6m)
USDFY, 2016FY, 2017FY, 2018

Cash

1.7m24.6m80.9m

Prepaid Expenses

86.0k1.1m

Current Assets

1.8m25.7m82.2m

PP&E

215.0k232.0k590.0k
Annual
USDFY, 2016FY, 2017FY, 2018

Net Income

(3.4m)(5.8m)(17.6m)

Depreciation and Amortization

16.0k43.0k89.0k

Accounts Payable

340.0k771.0k35.0k

Cash From Operating Activities

(2.4m)(5.8m)(15.3m)
Quarterly
USDQ2, 2017Q2, 2018

Net Income

(1.7m)(5.9m)

Depreciation and Amortization

42.0k39.0k

Accounts Payable

369.0k(273.0k)

Cash From Operating Activities

(1.3m)(6.3m)
USDY, 2018

Financial Leverage

1 x
Show all financial metrics

LogicBio Therapeutics Operating Metrics

Q2, 2018

Trademarks

2
Show all operating metrics

LogicBio Therapeutics Online and Social Media Presence

Embed Graph

LogicBio Therapeutics News and Updates

LogicBio Therapeutics Appoints Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical Development

CAMBRIDGE, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the appointment of Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical Develo…

Chardan Serves as Lead Manager for LogicBio Therapeutics

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead manager in the initial public offering of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), raising aggregate gross proceeds of approximately $70.0 million. LogicBio began...

LogicBio Therapeutics Blogs

LogicBio Therapeutics Receives Rare Pediatric Disease Designation for LB-001 for the Treatment of Methylmalonic Acidemia

LogicBio Therapeutics Receives Rare Pediatric Disease Designation for LB-001 for the Treatment of Methylmalonic Acidemia Content Import Tue, 07/16/2019 - 08:01 LogicBio Therapeutics Receives Rare Pediatric Disease Designation for LB-001 for the Treatment of Methylmalonic Acidemia …

LogicBio Secures Up To $20 Million Debt Facility with Oxford Finance LLC and Horizon Technology Finance

CAMBRIDGE, Mass. , July 02, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the closing of a $20 million secured debt facility with Oxford Finance

LogicBio Therapeutics Frequently Asked Questions

  • When was LogicBio Therapeutics founded?

    LogicBio Therapeutics was founded in 2014.

  • Who are LogicBio Therapeutics key executives?

    LogicBio Therapeutics's key executives are Frederic Chereau.

  • How many employees does LogicBio Therapeutics have?

    LogicBio Therapeutics has 23 employees.

  • Who are LogicBio Therapeutics competitors?

    Competitors of LogicBio Therapeutics include Immunocore, Agenus and ARCA biopharma.

  • Where is LogicBio Therapeutics headquarters?

    LogicBio Therapeutics headquarters is located at 610 Main St 3rd Floor, Cambridge.

  • Where are LogicBio Therapeutics offices?

    LogicBio Therapeutics has an office in Cambridge.

  • How many offices does LogicBio Therapeutics have?

    LogicBio Therapeutics has 1 office.